Adimmune Corporation reported earnings results for the second quarter and six months ended June 30, 2022. For the second quarter, the company reported sales was TWD 526.94 million compared to TWD 88.02 million a year ago. Net income was TWD 45.3 million compared to net loss of TWD 162.98 million a year ago. Basic earnings per share from continuing operations was TWD 0.11 compared to basic loss per share from continuing operations of TWD 0.38 a year ago. Diluted earnings per share from continuing operations was TWD 0.11 compared to diluted loss per share from continuing operations of TWD 0.38 a year ago. Basic earnings per share was TWD 0.11 compared to basic loss per share of TWD 0.38 a year ago. Diluted earnings per share was TWD 0.11 compared to diluted loss per share of TWD 0.38 a year ago.
For the six months, sales was TWD 579.73 million compared to TWD 94.95 million a year ago. Net loss was TWD 189.31 million compared to TWD 412.78 million a year ago. Basic loss per share from continuing operations was TWD 0.44 compared to TWD 0.96 a year ago. Diluted loss per share from continuing operations was TWD 0.44 compared to TWD 0.96 a year ago. Basic loss per share was TWD 0.44 compared to TWD 0.96 a year ago. Diluted loss per share was TWD 0.44 compared to TWD 0.96 a year ago.